Science News: A Study on the Epidemiology of COVID-19 Related Guillain-Barré Syndrome in the United States
Published January 30, 2025
Science News
Submitted by: Oksana Sayko, MD
Edited by: Nakul Katyal, MD
Citation: Sharma A, Sharma A, Soubani AO. A study on the epidemiology of COVID-19-related Guillain-Barré syndrome in the United States. J Clin Neuromuscul Dis. 2024;25(4):178-183. doi:10.1097/CND.0000000000000480
Summary: Several neurological complications have been reported with COVID-19, including Guillain–Barré syndrome (GBS). Researchers looked at incidence, baseline characteristics, and in-hospital outcomes of COVID 19–associated GBS in the United States.
A retrospective analysis was conducted using the USA National Inpatient Sample (NIS) database to identify hospitalizations for COVID-19 and GBS, using International Classification of Disease. The study examined factors associated with GBS using the April–December 2020 NIS database. The NIS is a publicly available all-payer database of USA inpatient hospitalizations, providing nationally representative estimates.
The study findings underscore GBS as a rare yet severe complication of COVID-19, highlighting a significant difference in mortality when compared with GBS not associated with COVID-19.
Comments: Interesting comprehensive study on COVID-19 related GBS. This study provides the first comprehensive analysis of GBS associated with COVID-19 using a large US inpatient